Evox Therapeutics Acquires Exosome AAV Technology & Intellectual Property
Evox Therapeutics, a leading biotechnology company, announced its acquisition of Exosome AAV technology and intellectual property, marking a significant milestone in the company's growth and development. Exosomes, tin...